SCHEMBL12468893

SCHEMBL12468893

Cn1ccnc1SCCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
DRD2 P14416 5/20 0.51
DRD3 P35462 4/20 0.51
ADRA1A P35348 3/20 0.51
ALDH1A1 P00352 3/20 0.50
HTR7 P34969 3/20 0.50
KDM4E B2RXH2 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12468732 0.94 DRD2 (0.54) SIGMAR1NPC1RAB9ADRD2DRD3
SCHEMBL12469195 0.84 KCNH2 (0.54) SIGMAR1DRD3ADRA1AHTR7HTR1A
SCHEMBL12468880 0.78 DRD2 (0.46) SIGMAR1RAB9ADRD2DRD3ADRA1A
SCHEMBL12469081 0.77 KCNH2 (0.58) SIGMAR1DRD2DRD3ADRA1AALDH1A1
SCHEMBL12469526 0.77 NPSR1 (0.63) SIGMAR1DRD2DRD3ADRA1AALDH1A1
SCHEMBL7680682 0.77 SIGMAR1 (0.53) SIGMAR1DRD2DRD3ADRA1AALDH1A1
Hydrochloric Acid SCHEMBL10572868 0.77 SIGMAR1 (0.48) SIGMAR1DRD2ALDH1A1HTR7KDM4E
SCHEMBL9537865 0.77 SIGMAR1 (0.53) SIGMAR1DRD2DRD3ADRA1AALDH1A1
SCHEMBL7677748 0.76 SIGMAR1 (0.54) SIGMAR1DRD2DRD3ADRA1AHTR7
Hydrochloric Acid SCHEMBL10577489 0.75 MAPT (0.47) SIGMAR1DRD2ALDH1A1HTR7SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289047-A1 HETEROARYLTHIO DERIVATIVES AND ANALOGUES EPIOMED THERAPEUTICS, INC. (US) 2013-10-31 US claimed
WO-2012051601-A2 HETEROARYLTHIO COMPOUNDS EPIOMED THERAPEUTICS, INC. (US) 2012-04-19 WO claimed
US-20130289047-A1 HETEROARYLTHIO DERIVATIVES AND ANALOGUES EPIOMED THERAPEUTICS, INC. (US) 2013-10-31 US disclosed
WO-2012051601-A2 HETEROARYLTHIO COMPOUNDS EPIOMED THERAPEUTICS, INC. (US) 2012-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130289047-A1 HETEROARYLTHIO DERIVATIVES AND ANALOGUES NLN, HTT, ABAT SIGMAR1 1706/4885NPC1 102/4885RAB9A 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.